+86(1812)4514114 [email protected]

Semaglutide (910463-68-2)

Enfuvirtide (also known as T-20) is a fusion inhibitor anti-AIDS targeted drug. Enfuvirtide is a 36………

Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1357kg/month


Semaglutide (910463-68-2) video


Semaglutide (910463-68-2) Description

Semaglutide is a GLP-1 Receptor Agonist. The mechanism of action of semaglutide is as a Glucagon-like Peptide-1 (GLP-1) Agonist. The chemical classification of semaglutide is Glucagon-Like Peptide 1.

Semaglutide is a once-daily glucagon-like peptide-1 analog that differs to others by the presence of an acyl group with a steric diacid at Lys26 and a large synthetic spacer and modified by the presence of a α-aminobutyric acid in position 8 which gives stability against the dipeptidylpeptidase-4.[A31421] The stability of semaglutide by the acylation permits a high-affinity albumin binding and gives it a long plasma half-life which allows the once-daily dosage. It was developed by the Danish pharmaceutical company Novo Nordisk and FDA approved on December 5, 2017.

Semaglutide (910463-68-2) Specifications

Product Name Semaglutide
Chemical Name Ozempic; UNII-53AXN4NNHX; NN9535; 53AXN4NNHX;
Brand Name Ozempic
Drug Class Peptide
CAS Number 910463-68-2
Molecular Formula C187H291N45O59
Molecular Weight 4113.641 g/mol
Monoisotopic Mass 4113.64
Melting Point  N/A
Freezing Point N/A
Biological Half-Life One week
Color Blue
Solubility  Soluble in aqueous solution (5% AcOH) (1mg/ml).
Storage Temperature  Stable for at least 1 year after receipt when stored at -20°C.
Application Antidiabetics, Glucagon-like Peptide-1 Agonists




There are no reviews yet.

Be the first to review “Semaglutide (910463-68-2)”

Your email address will not be published. Required fields are marked *

Shangke Chemical is a high-tech enterprise specializing in active pharmaceutical intermediates (APIs). To control the quality during production, a large number of experienced professionals, a first-class production equipment and laboratories are the key points.

Contact Us